检索历史清除

首页> Blood: The Journal of the American Society of Hematology> Enasidenib (AG-221), a Potent Oral Inhibitor of Mutant Isocitrate Dehydrogenase 2 (IDH2) Enzyme, Induces Hematologic Responses in Patients with Myelodysplastic Syndromes (MDS)

Enasidenib (AG-221), a Potent Oral Inhibitor of Mutant Isocitrate Dehydrogenase 2 (IDH2) Enzyme, Induces Hematologic Responses in Patients with Myelodysplastic Syndromes (MDS)

导出原文传递

翻译打印收藏纠错

作者： Stein, Eytan M. ; Fathi, Amir T. ; DiNardo, Courtney D. ; Pollyea, Daniel A. ; Swords, Ronan T. ; Roboz, Gail J. ; Collins, Robert ; Sekeres, Mikkael A. ; Stone, Richard M. ; Attar, Eyal C. ; Tosolini, Alessandra ; Xu, Qiang ; Amatangelo, Michael ; Gupta, Ira ; Knight, Robert D. ; De Botton, Stephane ; Tallman, Martin S. ; Kantarjian, Hagop M.

发布时间 2020-08-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交